How Much CVS Stock Are You Really Betting On?

You may not have bought this single stock, but your funds quietly made it one of your biggest positions.

CVS Health (CVS) stock has returned a striking +75% over the past year, and if you own common exchange-traded funds, you almost certainly own a piece of it. As a major healthcare services and pharmacy provider, CVS is a staple holding. But after a run that has pushed the stock about 31% above its 200-day moving average, the quiet, indirect position you hold in your funds may have become a concentrated bet you never intended to make.

How Stretched Has The Stock Become?

A stock running well ahead of its own long-term trend is not necessarily a problem, but it is a fact worth seeing clearly. CVS has had a good year, highlighted by a +41% return in the last three months alone. The stock trades at about 14 times expected earnings with profits forecast to grow 14% annually, yielding a fair valuation profile on fundamental metrics. However, its sharp run-up to 31% above its 200-day moving average is what makes investors question if technical momentum has outpaced fundamentals.

Which Of Your Funds Are Riding It Hardest?

This single-stock exposure is scattered across the fund landscape. CVS is held in 43 of the equity funds in our universe, but the concentration varies widely. The iShares U.S. Healthcare Providers ETF (IHF) is the most exposed, holding about 14.5% of its assets in CVS. That heavy weight helped power its +29% return over the past year. Other broad healthcare funds carry far less. The State Street Health Care Select Sector SPDR ETF (XLV) holds CVS at about 2.2% of the fund, while the Vanguard Health Care ETF (VHT) holds it at about 1.8%. The very concentration that fueled gains on the way up becomes the source of risk on the way down.

What A Pullback Would Actually Cost You

This is not a prediction, but a transparent scenario. If CVS simply fell back to its 200-day average, the stock would drop about 23% from its current price. For the funds holding it, the math is direct. That 23% drop in CVS would shave about 3.4% off the value of the iShares U.S. Healthcare Providers ETF (IHF) from this one holding alone. For the more diversified Vanguard Health Care ETF (VHT), the loss would be about 0.4%. This exposure is also sticky. You cannot surgically sell just the CVS shares inside your ETF. To reduce the position, you would have to sell the entire fund, potentially creating a taxable capital gain and unwinding a position you otherwise want to keep.

An Option For Broad Value Exposure With Less Risk

There are ways to maintain broad market exposure without carrying so much weight in one name. Consider the iShares MSCI USA Value Factor ETF (VLUE). It holds CVS at about 1.5% of the fund, far less than the 14.5% in the more concentrated IHF. It offers a different risk profile while still delivering strong performance, having returned +70% over the past year. This is not a directive to switch, but an example of how you can find similar exposure with significantly less single-stock concentration.

The goal here is awareness. A stock that has performed this well can feel like a permanent winner, but its weight in your portfolio may have grown beyond your comfort zone without you ever buying a single share directly. Knowing your true exposure is the first step to managing it.

How Do You Find A Better-Balanced Fund?

Whether this is a name you are happy to keep riding or one you would rather not own quite so much of, the first move is the same: see your true exposure to it, then find funds that carry the same theme with less of any single stock. A fund’s name tells you almost nothing about how concentrated it has quietly become.

Our ETF Valuation and Performance Scorecard ranks the major ETFs side by side on valuation, return, and risk, so you can see which funds lean hardest on a handful of names and which spread the exposure while keeping the performance.

Is There A Cleaner Way To Invest?

And if the whole problem, a winner quietly growing into an outsized, hard-to-trim position you never sized on purpose, is something you would rather avoid by design, there is another way to think about it. An index fund holds whatever its benchmark dictates and never trims a winner for you, so concentration builds silently until a pullback does the trimming.

Our High Quality (HQ) Portfolio takes the opposite approach: rule-based, multi-factor selection across different kinds of businesses, re-balanced on a schedule, so winners get trimmed and no single name quietly becomes the whole position. It has a record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000.